GeneDx Holdings Corp. – NASDAQ:WGSWW
GeneDx Holdings Corp. stock price today
$0.088
-0.06
-44.41%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 2 days
GeneDx Holdings Corp. stock price monthly change
+352.46%
month
GeneDx Holdings Corp. stock price quarterly change
+352.46%
quarter
GeneDx Holdings Corp. stock price yearly change
+1552.63%
year
GeneDx Holdings Corp. key metrics
Market Cap | 4.11M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -5.25 |
Revenue | 221.84M |
EBITDA | -81.95M |
Income | -135.01M |
Revenue Q/Q | 44.69% |
Revenue Y/Y | -0.91% |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | -36.94% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeGeneDx Holdings Corp. stock price history
GeneDx Holdings Corp. stock forecast
GeneDx Holdings Corp. financial statements
| Jun 2023 | 48.70M | -46.71M | -95.92% |
|---|---|---|---|
| Sep 2023 | 53.30M | -42.28M | -79.33% |
| Dec 2023 | 57.41M | -25.77M | -44.89% |
| Mar 2024 | 62.42M | -20.23M | -32.42% |
| Jun 2023 | 476390000 | 180.27M | 37.84% |
|---|---|---|---|
| Sep 2023 | 417285000 | 163.02M | 39.07% |
| Dec 2023 | 473674000 | 245.65M | 51.86% |
| Mar 2024 | 394528000 | 187.31M | 47.48% |
| Jun 2023 | -53.50M | -11.27M | 7.38M |
|---|---|---|---|
| Sep 2023 | -40.97M | -27.37M | -911K |
| Dec 2023 | -29.85M | -4.86M | 47.10M |
| Mar 2024 | -16.41M | 843K | -438K |
GeneDx Holdings Corp. alternative data
| Jan 2024 | 1,100 |
|---|---|
| Feb 2024 | 1,100 |
| Mar 2024 | 1,000 |
| Apr 2024 | 1,000 |
| May 2024 | 1,000 |
| Jun 2024 | 1,000 |
| Jul 2024 | 1,000 |
GeneDx Holdings Corp. other data
-
What's the price of GeneDx Holdings Corp. stock today?
One share of GeneDx Holdings Corp. stock can currently be purchased for approximately $0.09.
-
When is GeneDx Holdings Corp.'s next earnings date?
Unfortunately, GeneDx Holdings Corp.'s (WGSWW) next earnings date is currently unknown.
-
Does GeneDx Holdings Corp. pay dividends?
No, GeneDx Holdings Corp. does not pay dividends.
-
How much money does GeneDx Holdings Corp. make?
GeneDx Holdings Corp. has a market capitalization of 4.11M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 13.69% to 202.57M US dollars.
-
What is GeneDx Holdings Corp.'s stock symbol?
GeneDx Holdings Corp. is traded on the NASDAQ under the ticker symbol "WGSWW".
-
What is GeneDx Holdings Corp.'s primary industry?
Company operates in the Healthcare sector and Medical - Healthcare Information Services industry.
-
How do i buy shares of GeneDx Holdings Corp.?
Shares of GeneDx Holdings Corp. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does GeneDx Holdings Corp. have?
As Jul 2024, GeneDx Holdings Corp. employs 1,000 workers.
-
What is GeneDx Holdings Corp.'s official website?
The official website for GeneDx Holdings Corp. is genedx.com.
-
How can i contact GeneDx Holdings Corp.?
GeneDx Holdings Corp. can be reached via phone at +888 7291206.
GeneDx Holdings Corp. company profile:
GeneDx Holdings Corp.
genedx.comExchange:
NASDAQ
Full time employees:
1,000
Industry:
Medical - Healthcare Information Services
Sector:
Healthcare
GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.
North Tower
Stamford, 06902
Stamford, 06902
CIK: 0001818331
ISIN: US81663L1199
:
